OTCMKTS:ERFSF

Eurofins Scientific Stock Forecast, Price & News

$107.50
+0.70 (+0.66 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$104.00
Now: $107.50
$107.50
50-Day Range
$87.60
MA: $95.96
$106.80
52-Week Range
$48.50
Now: $107.50
$107.00
Volume332 shs
Average Volume1,136 shs
Market Capitalization$19.14 billion
P/E Ratio47.57
Dividend YieldN/A
Beta0.82
Eurofins Scientific SE, through its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as for clinical diagnostic. It provides agro science, agro testing, biopharma, contract development and manufacturing organization, clinical diagnostics, consumer product testing, digital testing, electrical and electronics, environment testing, food and feed testing, forensic, genomic, industrial, materials and engineering, medical device, and REACH services. The company serves clients from a range of industries, including the pharmaceutical, food, environmental, and clinical diagnostics sectors. It operates approximately 800 laboratories in 50 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
Eurofins Scientific logo

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ERFSF
Previous SymbolNASDAQ:ERFSF
CUSIPN/A
CIKN/A
Phone32-2766-1620
Employees51,516
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.19 billion
Cash Flow$5.58 per share
Book Value$18.24 per share

Profitability

Miscellaneous

Market Cap$19.14 billion
Next Earnings DateN/A
OptionableNot Optionable

Headlines

News for Eurofins Scientific SE
December 23, 2020 |  markets.businessinsider.com
See More Headlines

MarketRank

Overall MarketRank

0.88 out of 5 stars

Medical Sector

1146th out of 2,024 stocks

Private Households Industry

171st out of 378 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -
$107.50
+0.70 (+0.66 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ERFSF News and Ratings via Email

Sign-up to receive the latest news and ratings for ERFSF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Eurofins Scientific (OTCMKTS:ERFSF) Frequently Asked Questions

Is Eurofins Scientific a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eurofins Scientific in the last year. There are currently 2 sell ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Eurofins Scientific stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ERFSF, but not buy additional shares or sell existing shares.
View analyst ratings for Eurofins Scientific
or view top-rated stocks.

What stocks does MarketBeat like better than Eurofins Scientific?

Wall Street analysts have given Eurofins Scientific a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Eurofins Scientific wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Eurofins Scientific's stock been impacted by Coronavirus?

Eurofins Scientific's stock was trading at $495.50 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ERFSF stock has decreased by 78.3% and is now trading at $107.50.
View which stocks have been most impacted by COVID-19
.

Who are Eurofins Scientific's key executives?

Eurofins Scientific's management team includes the following people:
  • Dr. Gilles G. Martin, Chairman & CEO (Age 58)
  • Ms. Valerie Hanote, Exec. Director (Age 55)
  • Dr. Yves-Loïc Martin, Exec. Director (Age 55)
  • Mr. Laurent Lebras, Group Admin. & Fin. Director
  • Mr. Dirk Bontridder, Group Exec. VP of Pres Pharmaceutical Services & Member of Management Board (Age 48)
  • Dr. Markus Brandmeier, Group Exec. VP of Food Testing & Member of The Exec. Board (Age 57)

Who are some of Eurofins Scientific's key competitors?

What is Eurofins Scientific's stock symbol?

Eurofins Scientific trades on the OTCMKTS under the ticker symbol "ERFSF."

How do I buy shares of Eurofins Scientific?

Shares of ERFSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Eurofins Scientific's stock price today?

One share of ERFSF stock can currently be purchased for approximately $107.50.

How much money does Eurofins Scientific make?

Eurofins Scientific has a market capitalization of $19.14 billion and generates $5.19 billion in revenue each year. The company earns $218.74 million in net income (profit) each year or $2.26 on an earnings per share basis.

How many employees does Eurofins Scientific have?

Eurofins Scientific employs 51,516 workers across the globe.

What is Eurofins Scientific's official website?

The official website for Eurofins Scientific is www.eurofins.com.

Where are Eurofins Scientific's headquarters?

Eurofins Scientific is headquartered at 23 Val Fleuri, Luxembourg N4, 1526.

How can I contact Eurofins Scientific?

Eurofins Scientific's mailing address is 23 Val Fleuri, Luxembourg N4, 1526. The company can be reached via phone at 32-2766-1620 or via email at [email protected]


This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.